NCT02422108View on ClinicalTrials.gov

TNFSF11 Inhibition and Fertility: a Prospective Study

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

February 28, 2017

Study Completion Date

January 31, 2019

Conditions
TestisInfertilitySperm
Interventions
DRUG

Denosumab

Trial Locations (1)

2100

Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Martin Blomberg Jensen

OTHER

NCT02422108 - TNFSF11 Inhibition and Fertility: a Prospective Study | Biotech Hunter | Biotech Hunter